RECRUITINGOBSERVATIONAL
Prevalence of Synovitis in Patients With Haemophilia A
Prevalence of Synovitis in Adult Patients With Haemophilia A in Germany and Austria
About This Trial
The aim of this study is to evaluate the prevalence of synovitis in adult patients with haemophilia A.
Who May Be Eligible (Plain English)
Who May Qualify:
- Participants (≥ 18 years old) suffering from moderate or severe haemophilia A, also with inhibitor or joint replacement
- Complete documentation of hemophilia severity, treatment history (past 12 months), and bleeding events (past 12 months), inhibitor status (at time of enrollment and in past medical history)
- Submitted written consent to participate in the study
Who Should NOT Join This Trial:
- Patients suffering from other bleeding disorders conflicting with the research question
- Patients in clinical studies with investigational drugs
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Participants (≥ 18 years old) suffering from moderate or severe haemophilia A, also with inhibitor or joint replacement
* Complete documentation of hemophilia severity, treatment history (past 12 months), and bleeding events (past 12 months), inhibitor status (at time of enrollment and in past medical history)
* Submitted written consent to participate in the study
Exclusion Criteria:
* Patients suffering from other bleeding disorders conflicting with the research question
* Patients in clinical studies with investigational drugs
Treatments Being Tested
DIAGNOSTIC_TEST
Hemophilia Early Arthropathy Detection with Ultrasound (HEAD-US); Haemophilia joint health score (HJHS)
Each subject is examined for the presence of synovitis using the aforementioned diagnostics.
Locations (1)
University Hospital Bonn
Bonn, North Rhine-Westphalia, Germany